q&aconnectdiscussionssectionslatest
old postsmainaboutupdates

Sanofi's Opella Gains FDA Approval for OTC Cialis Study

January 22, 2025 - 02:37

Sanofi's Opella Gains FDA Approval for OTC Cialis Study

After facing a regulatory setback in 2022, Sanofi’s consumer healthcare division, Opella, has received approval from the FDA to advance its efforts to transition its erectile dysfunction medication, Cialis, from prescription to over-the-counter (OTC) status. This marks a significant milestone for the company, which had previously encountered challenges due to concerns over the study's protocol design.

The FDA's initial hold on the prescription-to-OTC study raised questions about the methodology and safety measures proposed by Opella. Following a thorough review and subsequent modifications to the study design, the agency has now granted the green light, allowing the company to proceed with its research.

The move to make Cialis available OTC could potentially enhance accessibility for individuals seeking treatment for erectile dysfunction, reflecting a growing trend in the healthcare industry to simplify access to medications. As Opella embarks on this new phase, the outcomes of the study will be closely monitored by both healthcare professionals and consumers alike.


MORE NEWS

Health Insights: The Role of Law in Addressing Health Issues

November 21, 2026 - 23:10

Health Insights: The Role of Law in Addressing Health Issues

The O`Neill Institute emphasizes the importance of law as a key instrument in tackling significant health challenges. In a world where health disparities continue to affect millions, legal...

Lynchburg Lab Expands to Enhance Livestock Health and Food Testing

November 21, 2026 - 15:51

Lynchburg Lab Expands to Enhance Livestock Health and Food Testing

A lab in Lynchburg is undergoing significant expansion to keep pace with advancements in livestock health and food testing technology. This facility is one of three in Virginia that are being...

MAHA Institute Faces Financial Challenges After First Year

November 20, 2026 - 22:04

MAHA Institute Faces Financial Challenges After First Year

Recent tax filings reveal that the MAHA Institute experienced significant financial strain in its inaugural year. The organization spent over $1 million in 2025, leaving it with a mere $171,000 in...

R. Gowtham Celebrates Health Workers in 'Superman Vivagaram'

November 20, 2026 - 14:27

R. Gowtham Celebrates Health Workers in 'Superman Vivagaram'

R. Gowtham`s debut film, `Superman Vivagaram,` made a strong impression at the Berlinale, where it garnered attention for its unique blend of dark comedy and social commentary. The film, which is...

read all news
q&aconnectdiscussionssectionslatest

Copyright © 2026 JogBee.com

Founded by: Holly Ellison

old postsmaintop picksaboutupdates
privacycookie infoterms